Morning Briefing
Summaries of health policy coverage from major news organizations
Medicare Will Still Cover Avastin For Breast Cancer, Despite Revocation Of FDA Approval
The FDA announced that Avastin, while still approved for other cancers, is more harmful than helpful to breast cancer patients.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
